hiv-1

Documents about hiv-1

• Enhancement by Poly-ICLC During HIV-1 Infection#28307ClinicalTrials.gov
• Prevalence of HTLV-1 and HTLV-2 infection among transgender women in Brazil: A multicenter study#437348PLOS
• Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals#833793ClinicalTrials.gov
• Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid#840917ClinicalTrials.gov
• Safety Study of Elvucitabine in HIV-1 Subjects#906135ClinicalTrials.gov
• immature HIV-1#361653CaltechDATA
• A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects#855639ClinicalTrials.gov
• Towards HIV Functional Cure#906822ClinicalTrials.gov
• Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation#829492ClinicalTrials.gov
• The Detection of Drug-Resistant HIV-1 in Taiwan#835033ClinicalTrials.gov
• Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men#826954ClinicalTrials.gov
• Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF#891507ClinicalTrials.gov
• CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS#864012ClinicalTrials.gov
• Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis#905047ClinicalTrials.gov
• An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons#887700ClinicalTrials.gov
• A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers#230477ClinicalTrials.gov
• Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection#981641ClinicalTrials.gov
• The landscape of ifn/isg signaling in hiv-1-infected macrophages and its possible role in the hiv-1 latency#948296Repositorio de Universidad Autónoma de Chile.
• Study of Novel Antiretrovirals in Participants With HIV-1#871442ClinicalTrials.gov
• HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia#831398ClinicalTrials.gov
• Novel Interventions in HIV-1 Infection#804916ClinicalTrials.gov
• Phase 1 Safety Study of Two Experimental HIV Vaccines#806647ClinicalTrials.gov
• 10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults#394599ClinicalTrials.gov
• Exploration of HIV Reservoirs#837563ClinicalTrials.gov
• Immune Response to Hepatitis C Virus#914292ClinicalTrials.gov
• Intestinal Tissue-Resident Memory T Cells and HIV-1 Persistence During Antiretroviral Therapy#866522ClinicalTrials.gov
• An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects#874580ClinicalTrials.gov
• H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients#870518ClinicalTrials.gov
• Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial#993423ClinicalTrials.gov
• Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults#840369ClinicalTrials.gov
• Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART#993475ClinicalTrials.gov
• In vitro diagnostic medical devices used for the quantitative detection of HIV-1 nucleic acid#267429WHO IRIS
• Striking HIV-1 Entry by Targeting HIV-1 gp41. But, Where Should We Target?#7881HAL (France)
• Simplifying Treatment and Monitoring for HIV (STREAM HIV)#845701ClinicalTrials.gov
• BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:#640444ClinicalTrials.gov
• Study of GS-3242 in Participants With HIV-1; Substudy-05#839500ClinicalTrials.gov
• HIV PrEP Priming of Immune Effectors#889591ClinicalTrials.gov
• Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART#904810ClinicalTrials.gov
• A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers#311201ClinicalTrials.gov
• Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir#915174ClinicalTrials.gov
• Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults#893706ClinicalTrials.gov
• Dendritic Cell Vaccine in HIV-1 Infection#350007ClinicalTrials.gov
• Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection#268066ClinicalTrials.gov
• Characterization of Acute and Recent HIV-1 Infections in Zurich.#909507ClinicalTrials.gov
• HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs#852024ClinicalTrials.gov
• Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1#832490ClinicalTrials.gov
• A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1#847283ClinicalTrials.gov
• The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs#838354ClinicalTrials.gov
• Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment#1008495ClinicalTrials.gov
• A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma#885227ClinicalTrials.gov

Related topics